Sublingual Advantage Leverage Allergy Easy’s at-home sublingual immunotherapy model to target consumers seeking convenient, cost-competitive allergy treatment without weekly clinic visits, appealing to patients and providers looking to reduce visit burdens.

Direct-to-Consumer Focus Capitalize on a Shopify-based channel and consumer-friendly delivery to expand DTC sales, partner with healthcare retailers, and explore bundling with over-the-counter allergy products to grow share.

Clinical Validation Highlight 25 years of clinical use to build trust with primary care physicians, allergists, and telehealth platforms, enabling partnerships, referrals, and sponsored trials to drive adoption.

Competitive Positioning Position as a cost-equivalent, more convenient alternative to injections, emphasizing reduced office visits and predictable out-of-pocket expenses to attract patients from traditional allergy shot providers.

Growth Synergies Target related allergy and immunology players with scalable white-label or distribution partnerships, leveraging current revenue range to pursue channel expansion and potential integrations with existing allergy product lines.